Funds holding BIOAFFINITY TECHNOLOGIES INC
ISIN US09076W3079 · United States
- Fund holders
- 6
- Of which ETFs
- 0 6 other funds
- Value held
- ≈ 171.8K $ 120.8K $ · 43.4K €
- Share of capital
- 1.2 % of 8.1M shares on Aug 3, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 55,543 | 45.1K $ | 0.69 % | as of Jun 30, 2026 ↗ | |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 28,059 | 46.9K $ | 0.00 % | 0.35 % | as of May 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 7,639 | 12.8K $ | 0.09 % | as of May 31, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 6,517 | 10.9K $ | 0.08 % | as of May 31, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 3,114 | 5.2K $ | 0.04 % | as of May 31, 2026 ↗ | |
| ABANTE QUANT VALUE, F.I. ABANTE ASESORES GESTION, SGIIC, S.A. | 43.4K € | 0.23 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| ABANTE QUANT VALUE, F.I. ABANTE ASESORES GESTION, SGIIC, S.A. | 0.23 % | as of Dec 31, 2025 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 5 | -3 | 100,872 | -9.9 % |
| 2026Q2 | 8 | +3 | 111,970 | +1,762.4 % |
| 2026Q1 | 5 | +4 | 6,012 | +56.8 % |
| 2025Q4 | 1 | 3,833 |
Institutional managers
12 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 48,293 | 185K $ | as of Mar 31, 2026 |
| J. Safra Sarasin Holding AG | 42,600 | 164K $ | as of Mar 31, 2026 |
| Schonfeld Strategic Advisors LLC | 24,413 | 93.5K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 14,386 | 55.1K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 12,725 | 48.7K $ | as of Mar 31, 2026 |
| UBS Group AG | 9,214 | 35.3K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 2,063 | 7.9K $ | as of Mar 31, 2026 |
| Ameritas Advisory Services, LLC | 1,000 | 3.8K $ | as of Mar 31, 2026 |
| IFP Advisors, Inc | 833 | 3.2K $ | as of Mar 31, 2026 |
| CITIGROUP INC | 57 | 218 $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 3 | 11 $ | as of Mar 31, 2026 |
| Caitong International Asset Management Co., Ltd | 1 | 4 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding BIOAFFINITY TECHNOLOGIES INC". https://titelia.com/en/stocks/bioaffinity-technologies-inc-US09076W3079